Skip to main content

What the FDA labels say about taking them together

Fluoroestradiol f 18 and fulvestrant

Fluoroestradiol f 18's FDA label of January 12, 2026 names fulvestrant in its drug interactions section; the fulvestrant labels PlainMeds reads (3) do not name fluoroestradiol f 18. The fluoroestradiol f 18 label: “Before administering CERIANNA, discontinue drugs that bind to the ER, such as SERMs and SERDs, for at least 5 biological half-lives.”

Check it at the source: the fluoroestradiol f 18 FDA label on DailyMed (effective January 12, 2026, GE Healthcare Inc.); the fulvestrant FDA label on DailyMed (effective September 25, 2020, AstraZeneca Pharmaceuticals LP).

What does the fluoroestradiol f 18 label say about fulvestrant?

Fluoroestradiol f 18 label, drug interactions

Before administering CERIANNA, discontinue drugs that bind to the ER, such as SERMs and SERDs, for at least 5 biological half-lives (e.g., elacestrant for 11 days, tamoxifen for 8 weeks, and fulvestrant for 28 weeks) [see Dosage and Administration (2.3) ].

Source: FDA drug label (CERIANNA), GE Healthcare Inc., effective January 12, 2026 (SPL set b2c2a2df-cf3e-4a29-a033-231ed5a94b58), via openFDA; the full label on DailyMed

What does the fulvestrant label say about fluoroestradiol f 18?

Fulvestrant's label (effective September 25, 2020) and its 2 other brand-application labels do not name fluoroestradiol f 18 in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (FASLODEX), AstraZeneca Pharmaceuticals LP, effective September 25, 2020 (SPL set 83d7a440-e904-4e36-afb5-cb02b1c919f7), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Fluoroestradiol f 18 generic labelers
19Fulvestrant generic labelers
Fluoroestradiol f 18Fulvestrant
Labeled forn/aBreast cancer
Boxed warningNoNo
Pharmacy cost (NADAC)n/an/a
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?